Results 151 to 160 of about 602,267 (275)

[Cyclic neutropenia: a case report and literatures review]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi, 2017
Shao YQ, Zheng YZ.
europepmc   +1 more source

Efficacy and Safety of Datopotamab Deruxtecan From a Single‐Institution Experience in Hormone Receptor–Positive, HER2‐Negative Metastatic Breast Cancer After Multiple Prior Therapies Including Antibody–Drug Conjugates

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background Datopotamab deruxtecan (Dato‐DXd) is a trophoblast cell surface antigen 2 (TROP2)–directed antibody–drug conjugate (ADC) with a topoisomerase I inhibitor payload and was approved by the Japan Pharmaceuticals and Medical Devices Agency in 2025 for patients with unresectable or recurrent hormone receptor–positive (HR+)/human epidermal
Hiroko Shimada   +18 more
wiley   +1 more source

Febrile neutropenia - Can it be Cyclic neutropenia?

open access: yesPediatric Oncall, 2017
Rajeev Ramachandran   +1 more
openaire   +1 more source

Age, Comorbidity Burden and Treatment Outcomes in Mature B‐Cell Lymphoproliferative Disorders: A Real‐World Study

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Introduction Treatment decisions in older patients with mature B‐cell lymphoproliferative disorders (MBLD) are frequently guided by chronological age and comorbidity burden, although their ability to predict clinically relevant outcomes remains uncertain.
Kevin Nasrinfar   +6 more
wiley   +1 more source

Canine Cyclic Neutropenia [PDF]

open access: yesJournal of Clinical Investigation, 1974
Paul L. Weiden   +4 more
openaire   +1 more source

Factors Associated With Recurrence After Adjuvant Gemcitabine and Nab‐Paclitaxel in Patients With Resected Pancreatic Ductal Adenocarcinoma

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background Pancreatic ductal adenocarcinoma (PDAC) carries a poor prognosis despite curative‐intent resection and adjuvant therapy. Gemcitabine plus nab‐paclitaxel (Gem‐NAP) has become a standard adjuvant regimen for PDAC, yet recurrence rates remain high.
Tao Xia   +7 more
wiley   +1 more source

Massive Pleural Synovial Sarcoma Presenting With Obstructive Shock

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Primary pleural synovial sarcoma (PPSS) is an exceptionally rare and aggressive malignancy. We report a massive PPSS characterized by positive TLE1 immunostaining but negative SS18–SSX Fluorescence in situ hybridization (FISH). This case highlights the importance of integrating morphology, immunohistochemistry, and clinical context when ...
Shenda Hou   +4 more
wiley   +1 more source

[A case report of cyclic neutropenia caused by novel double ELANE gene mutations]. [PDF]

open access: yesZhonghua Xue Ye Xue Za Zhi, 2018
Liu J, Jia JS, Jiang H.
europepmc   +1 more source

GATA2 Deficiency Presenting With a WHIM‐Like Phenotype and Subsequent Development of Monosomy 7‐Associated Myelodysplastic Syndrome in an Adolescent Female: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT We report an 18‐year‐old female with GATA2 deficiency presenting with a WHIM‐like phenotype, including pancytopenia, monocytopenia, CD19+ B‐cell depletion, sensorineural hearing loss, and cutaneous warts. Subsequent cytogenetic evaluation revealed monosomy 7 and 7q22 deletion, with bone marrow progression to MDS.
Aziz Eghbali   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy